Selection of blockbuster announcements

1、$BYD COMPANY (01211.HK)$Released half-year results, net profit 3.595 billion yuan, an increase of 206.35% over the same period last year

Byd Company Limited announced interim results for 2022. In the six months to June 30, 2022, the group's turnover was 150.607 billion yuan, an increase of about 65.71% over the same period last year. The gross profit was 20.342 billion yuan, an increase of about 75.35% over the same period last year. The profit attributable to the owners of the parent company was 3.595 billion yuan, an increase of about 206.35% over the same period last year. The earnings per share is 1.24 yuan.

During the period, the company's sales of new energy vehicles repeatedly reached record highs, the market share increased significantly, and the brand influence continued to expand; build a new brand matrix, expand new product series, and increase product innovation to lead the new trend of industry development. The business of electronic major customers continues to expand, the business field continues to expand, and the product structure is constantly optimized. The rapid growth in sales has contributed to a significant improvement in the company's profits and, to some extent, hedged the profit pressure caused by raw materials.

2、$HAIER SMARTHOME (06690.HK)$Net profit in the first half increased by 15.89% to 7.949 billion yuan

Haier Smart Home released the semi-annual report for 2022, the operating income for the reporting period was 121.858 billion yuan (the same as below), an increase of 9.07 percent over the same period last year; the net profit belonging to shareholders of listed companies was 7.949 billion yuan, up 15.89 percent over the same period last year; the net profit belonging to shareholders of listed companies after deducting non-recurring profits and losses was 7.491 billion yuan, up 19.47 percent over the same period last year; and basic earnings per share was 0.85 yuan.

3、$FOSUN PHARMA (02196.HK)$Half-year deduction of non-net profit was 1.862 billion yuan, an increase of 18.57% over the same period last year.

Shanghai Fosun Pharmaceutical released a semi-annual report for 2022, with operating income of 21.34 billion yuan, an increase of 25.88 percent over the same period last year. Net profit belonging to shareholders of listed companies was 1.547 billion yuan, down 37.67 percent from the same period last year. Net profit belonging to shareholders of listed companies after deducting non-recurring profits and losses was 1.862 billion yuan, up 18.57 percent over the same period last year; basic earnings per share was 0.60 yuan.

4、$CLOVER BIO-B (02197.HK)$The enhanced injection of COVID-19 candidate vaccine showed strong neutralization response to Omicron BA.5 mutant subtype.

Clover Biological-B released positive data from a phase II/III clinical trial that showed that the company's COVID-19 vaccine candidate SCB-2019 (CpG 1018 / aluminum adjuvant) induced a strong immune response to the subtype of O'Micron BA.2 and BA.1 variants in addition to the previously announced neutralization response to the subtypes of O'Micron BA.5, which is currently the dominant strain in the world. This new set of positive data provides more evidence to support SCB-2019 (CpG 1018 / aluminum adjuvant) as a universal COVID-19 vaccine booster against the most popular mutant strain of novel coronavirus.

5、$TENCENT (00700.HK)$Buy back 1.09 million shares at a cost of about HK $352 million

Tencent: 1.09 million shares were repurchased on August 29th at a repurchase price of HK $317-HK $324, at a total cost of about HK $352 million.

6、$XIAOMI-W (01810.HK)$Buy back 4.4 million shares at a cost of about HK $50.1125 million

XIAOMI Group: repurchased 4.4 million shares at a repurchase price of HK $11.36-HK $11.42, at a total cost of about HK $50.1125 million.

Listing of new shares

Tuhu car maintenance submitted an application for listing to the Hong Kong Stock Exchange

Financial data

Haier Smart Home (06690) first-half net profit increased by 7.949 billion compared with the same period last year.

The net profit of Shanghai Pharmaceutical (02607) reached 3.696 billion yuan in the first half of the year, up 3.58% from the same period last year.

China Taiping (00966) medium-term net profit attributable to shareholders decreased by 47.0% to HK $2.709 billion net investment income increased by 16.3%

China Software International (00354) first-half net profit of 572 million yuan increased by 10.4% compared with the same period last year.

BYD Electronic (00285) released the first-half results, the profit attributable to shareholders was 634 million yuan, down 61.43% from the same period last year.

DongFeng Motor Group (00489) released his first-half results with an income of 44.309 billion yuan and a profit attributable to shareholders of 5.529 billion yuan.

The net profit of Beijing Automobile (01958) fell 21.75% to 2.158 billion yuan in the first half of the year.

China Cinda (01359) first-half net profit of 4.508 billion yuan fell 32.6% compared with the same period last year.

Hypree (09989) announced interim results: both revenue and net profit rose, and all businesses achieved good growth.

Poly property (06049) medium-term net profit of 628 million yuan increased by 28.0% over the same period last year.

Sunac Services (01516) released interim income of 3.989 billion yuan, an increase of 18.5% over the same period last year. The construction area under management is about 234 million square meters.

Zhengtong Motor (01728) announced interim results: gross profit increased by 2961.3% to about 949 million yuan, while net profit was about 8 million yuan.

Huazhu Group Limited-S (01179) released a net loss of 980 million yuan in the interim results compared with the same period last year.

Huada Hotel (00201) medium-term net profit of HK $106 million increased 11 times compared with the same period last year.

Tianlun Gas (01600) medium-term income of 3.745 billion yuan increased by 4.0% compared with the same period last year.

China Zheshang Bank's net profit in the first half of 02016 was 6.974 billion yuan, up 1.8% from the same period last year.

Quack feeding (00520) medium-term loss of 280 million yuan increased by 459.95% compared with the same period last year

Half-yearly report of Foreign Exchange Technology (01860): revenue rose 48% year-on-year to $456 million, and adjusted EBITDA grew by 162% year-on-year.

Baycom Medical-B (02170) announced interim results: research and development expenditure increased by 99.53%, rapid construction of a complete pipeline of third-generation assisted reproduction products

Xintong Medical-B (02160) announced interim results: revenue increased by 44.77% to 125 million yuan and gross profit margin rose to 63.7%.

Development of Pharmaceutical Industry-B (09939) announced interim results, R & D costs of 461 million yuan, an increase of 63.4% over the same period last year.

Green Leaf Pharmaceutical (02186) released first-half results, profit attributable to shareholders decreased by 23.17% to 297 million yuan compared with the same period last year.

Jinyu Group (02009) first-half net profit of 1.836 billion yuan decreased by 3.99% compared with the same period last year.

Australian excellent (01717) interim net profit of 222 million yuan decreased by 62.9% compared with the same period last year.

CITIC (06030) released a net profit of 11.196 billion yuan for interim results, a decrease of 8.21% compared with the same period last year.

Agricultural Bank Of China (01288.HK) first-half net profit of 128.95 billion yuan increased by 4.98% compared with the same period last year.

Pharmaron Beijing Co., Ltd.* (03759) medium-term return profit of about 585 million yuan increased by about 3.6% compared with the same period last year.

Medium-term income of China United Plastics (02128) increased by 1.1% to 14.89 billion yuan.

Tuya Inc.-W (02391) released second-quarter results, with a net loss of $35.869 million, down 5.93% from a year earlier.

Important matters

Haier Smart Home (06690): plans to acquire 100% equity interest in specialty plastics company with 152 million yuan

China Huarong (02799) issues the Development Plan of the 14th five-year Plan

DongFeng Motor Group (00489) officially launched the luxury electric off-road brand fierce.

Clover organism-B (02197): COVID-19 candidate vaccine enhancement needle showed strong neutralization response to Omicron BA.5 mutant subtype.

Shanghai Fosun Pharmaceutical (02196) holding subsidiary plans to invest no more than 1 billion yuan to build "innovative Vaccine headquarters and industrialization Base Project"

Hongguang Semiconductor (06908) and General Electric Co enter into a global patent licensing agreement for high color gamut phosphor applications of light emitting diodes.

Repurchase cancellation

Tencent (00700) spent HK $352 million to buy back 1.09 million shares on August 29th.

XIAOMI Group-W (01810) spent HK $50.11 million to buy back 4.4 million shares on August 29th

Smoore International Holdings Limited (06969) spent HK $49.4366 million to buy back 3.6 million shares on August 29th.

Jinchuan International (02362) spent HK $4.2679 million to buy back 5 million shares on August 29th.

Pop Mart International (09992) spent HK $11.9167 million to buy back 615200 shares on August 29th.

AIA Group Limited (01299) spent HK $178 million to buy back 2.2996 million shares on August 29th.

Kerry Construction (00683) spent HK $3.6066 million to buy back 200000 shares on August 29th

Ming Yuan Cloud Group (00909) spent HK $4.634 million to buy back 747000 shares on August 29th.

Yi Da (01733) spent HK $12.453 million to buy back 7.374 million shares on August 29th.

Sino International (00732) spent HK $3.3096 million to buy back 1.894 million shares on August 29th

Swire AG A (00019) spent HK $14.857 million to repurchase 267000 shares on August 29th

Standard Chartered PLC (02888) spent 8.6947 million pounds to buy back 1.459 million shares on August 26th.

New Oriental Education & Technology Group-S (09901) bought back nearly $256 million of bonds.

Ping An Insurance (02318) accumulated 103 million A shares of the buyback company.

Equity incentive

INNOVENT BIO (01801) granted 127000 share options and 110000 restricted shares

Perfect Healthcare (01830) granted 1.282 million share options

Ruili Medical Beauty (02135) granted 109 million share options